SYST-14 CLINICAL EFFICACY OF ONC201 IN RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA (DMG) PATIENTS Article

Arrillaga-Romany, Isabel, Kurz, Sylvia, Tarapore, Rohinton et al. (2022). SYST-14 CLINICAL EFFICACY OF ONC201 IN RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA (DMG) PATIENTS . NOA, 4(Supplement_1), i24-i24. 10.1093/noajnl/vdac078.093

cited authors

  • Arrillaga-Romany, Isabel; Kurz, Sylvia; Tarapore, Rohinton; Lu, Guangrong; Sumrall, Ashley; Butowski, Nicholas; Harrison, Rebecca; DeGroot, John; Chi, Andrew; Shonka, Nicole; Umemura, Yoshie; Odia, Yazmin; Mehta, Minesh; Nghiemphu, Phioanh; Cloughesy, Timothy; Taylor, Lynne; Graber, Jerome; Kilburn, Lindsay; Dixit, Karan; Chen, Clark; Gardner, Sharon; Aguilera, Dolly; MacDonald, Tobey; Cluster, Andrew; Mehta, Kathan; Kheradpour, Albert; Melemed, Allen; Allen, Joshua E; Batchelor, Tracey; Lassman, Andrew; Wen, Patrick

authors

publication date

  • August 5, 2022

published in

  • NOA  Journal

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Health Disparities
  • Health Disparities and Racial or Ethnic Minority Health Research
  • Minority Health
  • Neurosciences
  • Pediatric Cancer
  • Pediatric Research Initiative
  • Rare Diseases

Digital Object Identifier (DOI)

start page

  • i24

end page

  • i24

volume

  • 4

issue

  • Supplement_1